MR编号 | DE/H/0214/001 |
---|
药品名称 | Hepatect CP |
---|
活性成分 | - Human hepatitis B immunoglobulin 50.0 IU/ml
|
---|
剂型 | Solution for infusion |
---|
上市许可持有人 | Biotest Pharma GmbH
Landsteinerstrasse 5
D-63303 Dreieich
Germany |
---|
参考成员国 - 产品名称 | Germany (DE) Hepatect CP |
---|
互认成员国 - 产品名称 | - Belgium (BE)
- Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Hepatect CP 50 I.E./ml Infusionslösung - Portugal (PT)
- Italy (IT)
- Greece (GR)
- Spain (ES)
- Poland (PL)
- Hungary (HU)
HEPATECT 50 NE/ml oldatos infúzió - Bulgaria (BG)
- Czechia (CZ)
- Romania (RO)
HEPATECT CP 50 UI/ml soluţie perfuzabilă - Slovenia (SI)
- Denmark (DK)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Croatia (HR)
- Lithuania (LT)
Hepetra 50 TV/ml infuzinis tirpalas
|
---|
许可日期 | 2001/12/21 |
---|
最近更新日期 | 2024/12/04 |
---|
药物ATC编码 | - J06BB04 hepatitis B immunoglobulin
|
---|
申请类型 | - TypeLevel1:New Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Full Dossier Article 4.8 Di 65/65
- TypeLevel4:Biological: Blood Product
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|